Barclays’s Fabrinet FN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-100
Closed -$5K 6829
2019
Q2
$5K Sell
100
-1,700
-94% -$89.8K ﹤0.01% 6685
2019
Q1
$94K Buy
+1,800
New +$98.1K ﹤0.01% 5405
2018
Q2
Sell
-3,400
Closed -$107K 7054
2018
Q1
$107K Sell
3,400
-200
-6% -$5.9K ﹤0.01% 5336
2017
Q4
$103K Buy
3,600
+2,800
+350% +$92.6K ﹤0.01% 5218
2017
Q3
$30K Sell
800
-2,100
-72% -$85.9K ﹤0.01% 5612
2017
Q2
$124K Buy
+2,900
New +$109K ﹤0.01% 4761

Other funds holding FN

Barclays's FN Position: Q2 2026 in Review

Barclays increased its Fabrinet (FN) stake by 80% in Q2 2026, buying an estimated $9.3M and bringing the position to 32,552 shares worth $18.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1178.

Barclays first reported a position in FN in Q2 2013 and has held it in 52 quarters since. The position peaked at $36.6M in Q4 2025. 758 funds tracked by Wall St. Rank hold FN as of Q2 2026.

  • Barclays held 32,552 shares of Fabrinet worth $18.3M as of Q2 2026.
  • Barclays bought 14,433 Fabrinet shares in Q2 2026, an estimated $9.3M.
  • Fabrinet made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1178 holding.
  • Barclays first reported a position in Fabrinet in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Fabrinet position peaked at $36.6M in Q4 2025.
  • 758 funds tracked by Wall St. Rank held Fabrinet as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.